HIGHLIGHTS
- who: Thibault Letellier et al. from the Institut de Transplantation Urologie Nu00e9phrologie (ITUN), Centre Hospitalo-Universitaire Nantes, Biotechnology and Bio Resources Development Laboratory, Faculty of Sciences, Moulay Ismail University have published the research: Time-Limited Therapy with Belatacept in KidneyTransplant Recipients, in the Journal: (JOURNAL) of 27/05/2022
- what: To go further the authors compare the DEGs betw skewed towards HCK) has been shown to decrease inflammation in different conditions D0 and M3 identified in the patients , with those associated with subclinical including experimental allograft . The study reports for the first time the implementation . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.